BAP1 and mesothelioma: There are notable differences in the clinical behaviour between sporadic mesothelioma and the form of mesothelioma associated with BAP1 TPS, with the latter having a less aggressive phenotype and patients with a higher median overall survival of 5–7 years [21, 22].